SYNthesis Research Pty Ltd Pharm Bio Unit Trust – Trademark Portfolio
Entity Type: 82
SYNthesis Research Pty Ltd Pharm Bio Unit Trust holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 1 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THE PHARM BIO. The owner is based in Parkville VIC 3052.
Bio21 Institute,
30 Flemington Road
Parkville VIC 3052 , AU
Showing of trademarks Trademarks
Trademark Classifications
SYNthesis Research Pty Ltd Pharm Bio Unit Trust's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does SYNthesis Research Pty Ltd Pharm Bio Unit Trust have?
SYNthesis Research Pty Ltd Pharm Bio Unit Trust has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does SYNthesis Research Pty Ltd Pharm Bio Unit Trust file in?
SYNthesis Research Pty Ltd Pharm Bio Unit Trust files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 45 (Legal & Security Services). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are SYNthesis Research Pty Ltd Pharm Bio Unit Trust's most well-known trademarks?
SYNthesis Research Pty Ltd Pharm Bio Unit Trust's registered trademark portfolio includes well-known marks such as THE PHARM BIO. These are among 1 currently registered trademark in the portfolio.
What is SYNthesis Research Pty Ltd Pharm Bio Unit Trust's trademark registration success rate?
SYNthesis Research Pty Ltd Pharm Bio Unit Trust has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.